李西廷2亿元增持迈瑞医疗，李西廷名下持股平台曾套现超百亿

Group 1 - The core viewpoint of the article highlights that despite a significant drop in the stock price of Mindray Medical, its actual controller, Li Xiting, has recently increased his stake by approximately 200 million yuan, which is relatively minor compared to previous large-scale reductions [1] - Since the beginning of 2023, Li Xiting and his holding platforms have significantly reduced their stakes, cashing out around 2.5 billion yuan in a single quarter, totaling over 10 billion yuan [1] - Industry insiders believe that the domestic medical and consumables procurement continues to face challenges, and the fundamental aspects of the industry have not yet bottomed out, while overseas operations are facing tariff-related risks [1] Group 2 - As of June 2023, the four holding platforms still collectively held 50 million shares of Mindray Medical, but by June 2025, they are expected to disappear from the list of the top ten shareholders [2] - The estimated cash-out amount from these reductions over the two-year period could exceed 10 billion yuan based on average stock prices [2]